Movatterモバイル変換


[0]ホーム

URL:


EDIZIONI MINERVA MEDICA
Login   Search

Home >Journals >Minerva Endocrinology >Past Issues >Minerva Endocrinologica 2018 September;43(3) >Minerva Endocrinologica 2018 September;43(3):261-84

 

OPEN ACCESS

YOUR ACCOUNT

YOUR ORDERS

SHOPPING BASKET

HOW TO ORDER

YOUR SUBSCRIPTIONS

YOUR ARTICLES

YOUR EBOOKS

COUPON

ACCESSIBILITY

CURRENT ISSUE
 

JOURNAL TOOLS

Journal policies
Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

REVIEW  CLINICAL DIAGNOSIS OF ENDOCRINE DISEASES 

Minerva Endocrinologica 2018 September;43(3):261-84

DOI:10.23736/S0391-1977.17.02764-X

Copyright © 2017 EDIZIONI MINERVA MEDICA

language: English

Clinical endocrinology and hormones quantitation: the increasing role of mass spectrometry

Federica D'AURIZIO1, Marco CANTÙ2

1 Department of Laboratory Medicine, Clinical Pathology Institute, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy;2 Laboratory of Clinical Biochemistry and Pharmacology, Department of Laboratory Medicine EOLAB, Ente Ospedaliero Cantonale, Bellinzona, Switzerland


PDF


Clinical endocrinology has always had a close relationship with laboratory medicine. In fact, the quantification of hormones is of great importance for diagnosis, treatment, recurrence and patient’s prognosis of endocrine disorders. This review dealt with the role of the laboratory in diagnosing endocrine pathologies related to adrenal gland, pituitary, gonads and thyroid. The measurements of the main hormones (17-hydroxyprogesterone, androstenedione, dehydroepiandrosterone sulphate, testosterone, estradiol, cortisol, aldosterone, metanephrines, thyroglobulin and insulin-like-growth factor-1) were described considering analytical characteristics but also some aspects of preanalytical and postanalytical steps. Traditionally, hormonal quantification is performed with immunoassays (IMAs), which have several advantages (i.e. limited training of technicians, high throughput, widely spread worldwide), but also some limitations on the accuracy of the results due mainly to cross-reactivity of IMA antibodies (i.e. steroid measurements) and protein interferences (i.e. heterophilic antibodies, antithyroglobulin antibodies in Tg measurements, etc.). In order to meet the need for clinicians to obtain ever more accurate results from laboratories, in recent decades, mass spectrometry (MS) has been developed. MS, in particular Liquid Chromatography-Tandem MS (LC-MS/MS), is a more complex but also more flexible technique able to guarantee greater specificity. It also provides multi-parameter quantification in the same analytical session delineating steroid profiles and, in some cases, defining the appropriate reference range for each hormone. Similar to IMAs, LC-MS/MS shows some inter-method variability, limiting the goal of standardization. However, several studies have recently demonstrated the possibility of reaching harmonization of this technology with good expectations for the future.


KEY WORDS: Endocrinology - Hormones - Immunoassays - Chromatography, liquid - Tandem mass spectrometry - Steroids

top of page

 

Copyright © 2026 Edizioni Minerva Medica

Corporate information        Privacy policy        Terms and conditions

Publication History

Issue published online: July 9, 2018
Article first published online: October 27, 2017
Manuscript accepted: October 25, 2017
Manuscript received: October 16, 2017

Cite this article as

D’Aurizio F, Cantù M. Clinical endocrinology and hormones quantitation: the increasing role of mass spectrometry. Minerva Endocrinol 2018;43:261-84. DOI: 10.23736/S0391-1977.17.02764-X

Corresponding author e-mail

marco.cantu@eoc.ch

Share


[8]ページ先頭

©2009-2026 Movatter.jp